Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)
India · Delayed Price · Currency is INR 47.40
+0.65 (1.39%)
At close: Jul 15, 2025
BOM:524396 Revenue
In the fiscal year ending March 31, 2025, Biofil Chemicals and Pharmaceuticals had annual revenue of 334.02M INR, down -17.34%. Biofil Chemicals and Pharmaceuticals had revenue of 83.51M in the quarter ending March 31, 2025, a decrease of -46.39%.
Revenue
334.02M
Revenue Growth
-17.34%
P/S Ratio
2.35
Revenue / Employee
12.85M
Employees
26
Market Cap
783.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 334.02M | -70.07M | -17.34% |
| Mar 31, 2024 | 404.09M | 103.74M | 34.54% |
| Mar 31, 2023 | 300.35M | 76.53M | 34.19% |
| Mar 31, 2022 | 223.82M | -134.27M | -37.50% |
| Mar 31, 2021 | 358.10M | 60.42M | 20.30% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |